Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Analytical Chemistry>Standard>Pharmaceutical Impurity Reference Standards>Ivabradine related compound 12(Hydrochloride)
Ivabradine related compound 12(Hydrochloride)
  • Ivabradine related compound 12(Hydrochloride)
  • Ivabradine related compound 12(Hydrochloride)
  • Ivabradine related compound 12(Hydrochloride)
  • Ivabradine related compound 12(Hydrochloride)
  • Ivabradine related compound 12(Hydrochloride)

Ivabradine related compound 12(Hydrochloride) NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-07-31

Product Details

Product Name: Ivabradine related compound 12(Hydrochloride) CAS No.: 1204612-29-2
Min. Order: 10mg Purity: 99%+ HPLC
Supply Ability: 1000 Release date: 2025/07/31

Ivabradine related compound 12(Hydrochloride);1204612-29-2


Article illustration

WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com


  • Ivabradine related compound 12(Hydrochloride)

  • Product Information

  • Product Code: I002012A

  • English Name: Ivabradine related compound 12(Hydrochloride)

  • English Alias: (R)-1-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)-N-methylmethanamine hydrochloride

  • CAS No.:1204612-29-2

  • Molecular Formula: C₁₂H₁₇NO₂·HCl

  • Molecular Weight: 243.73 (207.27 + 36.46)

  • Advantages

  • Structural Confirmation: Characterized by NMR, HRMS, and HPLC (≥98.5%) for reliable identification.

  • Stability: Stable for 18 months at 2-8℃, with <1% degradation in methanol-HCl solution.

  • Regulatory Compliance: Supports ICH Q3A/B guidelines for impurity profiling.

  • Applications

  • Quality Assurance: Used in HPLC/LC-MS for impurity detection in Ivabradine formulations, ensuring compliance with pharmacopoeia.

  • Synthesis Monitoring: Tracks amine hydrochloride formation during Ivabradine synthesis to optimize purification steps.

  • Analytical Method Validation: Validates specificity and linearity of detection methods.

  • Background Description

  • This impurity originates from incomplete cyclization or amine substitution in Ivabradine synthesis, a cardiac pacemaker inhibitor. Controlling such impurities is critical for maintaining drug efficacy and safety.
  • Research Status

  • Detection: HPLC with reversed-phase column (C18, 5μm) and phosphate buffer-acetonitrile elution; LOD: 0.05 μg/mL.

  • Formation Mechanism: Results from side reactions of dimethoxycycloalkene intermediates; optimized base catalysis reduces generation by 50%.

  • Safety Evaluation: In vitro cardiotoxicity tests show no significant effects at therapeutic concentrations; further toxicology studies pending


NOTE!

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com


NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery! 


Company Profile Introduction

-

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/1g
VIP2Y
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
2024-09-19
$0.00/10mg
VIP8Y
Guangzhou PI PI BIOTECH INC
2021-06-28
$0.00/5mg
VIP1Y
Guangzhou Tosun Pharmaceutical Ltd
2025-02-18
INQUIRY